Pages that link to "Q45300502"
Jump to navigation
Jump to search
The following pages link to Body weight is modulated by levels of full-length huntingtin (Q45300502):
Displaying 48 items.
- Role of cerebral cortex in the neuropathology of Huntington's disease (Q26829211) (← links)
- Iron dysregulation in Huntington's disease (Q26829932) (← links)
- Mouse models of polyglutamine diseases: review and data table. Part I (Q26853025) (← links)
- Ataxin-2 regulates RGS8 translation in a new BAC-SCA2 transgenic mouse model (Q27311213) (← links)
- Laquinimod rescues striatal, cortical and white matter pathology and results in modest behavioural improvements in the YAC128 model of Huntington disease. (Q27316866) (← links)
- Maintenance of basal levels of autophagy in Huntington's disease mouse models displaying metabolic dysfunction (Q27341821) (← links)
- Effects of deletion of mutant huntingtin in steroidogenic factor 1 neurons on the psychiatric and metabolic phenotype in the BACHD mouse model of Huntington disease (Q27346849) (← links)
- HdhQ111 Mice Exhibit Tissue Specific Metabolite Profiles that Include Striatal Lipid Accumulation (Q28386493) (← links)
- Unbiased gene expression analysis implicates the huntingtin polyglutamine tract in extra-mitochondrial energy metabolism (Q28469280) (← links)
- Serine 421 regulates mutant huntingtin toxicity and clearance in mice. (Q30355064) (← links)
- Systematic behavioral evaluation of Huntington's disease transgenic and knock-in mouse models (Q30483013) (← links)
- A fully humanized transgenic mouse model of Huntington disease. (Q30537951) (← links)
- Motivational, proteostatic and transcriptional deficits precede synapse loss, gliosis and neurodegeneration in the B6.HttQ111/+ model of Huntington's disease (Q30837903) (← links)
- Wild-type huntingtin ameliorates striatal neuronal atrophy but does not prevent other abnormalities in the YAC128 mouse model of Huntington disease (Q33265508) (← links)
- Peripheral huntingtin silencing does not ameliorate central signs of disease in the B6.HttQ111/+ mouse model of Huntington's disease (Q33614987) (← links)
- Full-length huntingtin levels modulate body weight by influencing insulin-like growth factor 1 expression (Q33755845) (← links)
- Sustained therapeutic reversal of Huntington's disease by transient repression of huntingtin synthesis. (Q34283652) (← links)
- Comparison of modules of wild type and mutant Huntingtin and TP53 protein interaction networks: implications in biological processes and functions (Q34760892) (← links)
- Weight loss in neurodegenerative disorders (Q34928711) (← links)
- Increased Body Weight of the BAC HD Transgenic Mouse Model of Huntington's Disease Accounts for Some but Not All of the Observed HD-like Motor Deficits. (Q34991104) (← links)
- Similar striatal gene expression profiles in the striatum of the YAC128 and HdhQ150 mouse models of Huntington's disease are not reflected in mutant Huntingtin inclusion prevalence (Q35874743) (← links)
- Hypothalamic overexpression of mutant huntingtin causes dysregulation of brown adipose tissue (Q36106687) (← links)
- Caspase-6 activity in a BACHD mouse modulates steady-state levels of mutant huntingtin protein but is not necessary for production of a 586 amino acid proteolytic fragment. (Q36266600) (← links)
- Novel BAC Mouse Model of Huntington's Disease with 225 CAG Repeats Exhibits an Early Widespread and Stable Degenerative Phenotype. (Q36315067) (← links)
- Expression of mutant huntingtin in leptin receptor-expressing neurons does not control the metabolic and psychiatric phenotype of the BACHD mouse (Q36459384) (← links)
- Protection by dietary restriction in the YAC128 mouse model of Huntington's disease: Relation to genes regulating histone acetylation and HTT. (Q36763900) (← links)
- Hypothalamic dysfunction and neuroendocrine and metabolic alterations in Huntington's disease: clinical consequences and therapeutic implications. (Q37003956) (← links)
- Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice (Q37072467) (← links)
- A Longitudinal Motor Characterisation of the HdhQ111 Mouse Model of Huntington's Disease (Q37089398) (← links)
- Genetic mouse models of Huntington's disease: focus on electrophysiological mechanisms (Q37731940) (← links)
- Screening of therapeutic strategies for Huntington's disease in YAC128 transgenic mice. (Q37866383) (← links)
- Choosing an animal model for the study of Huntington's disease (Q38139868) (← links)
- Astrocytes are key but indirect contributors to the development of the symptomatology and pathophysiology of Huntington's disease (Q38839272) (← links)
- Reduced motivation in the BACHD rat model of Huntington disease is dependent on the choice of food deprivation strategy (Q41979425) (← links)
- Metabolic profiling of presymptomatic Huntington's disease sheep reveals novel biomarkers (Q42320470) (← links)
- Mutant Huntingtin Causes Metabolic Imbalance by Disruption of Hypothalamic Neurocircuits (Q42486219) (← links)
- Striatal expression of a calmodulin fragment improved motor function, weight loss, and neuropathology in the R6/2 mouse model of Huntington's disease. (Q43275673) (← links)
- A novel BACHD transgenic rat exhibits characteristic neuropathological features of Huntington disease. (Q45290510) (← links)
- Motor deficits associated with Huntington's disease occur in the absence of striatal degeneration in BACHD transgenic mice (Q45293567) (← links)
- Histone Deacetylase Inhibitors Protect Against Pyruvate Dehydrogenase Dysfunction in Huntington's Disease. (Q45300176) (← links)
- Fat-free mass and its predictors in Huntington's disease (Q45305503) (← links)
- Marked differences in neurochemistry and aggregates despite similar behavioural and neuropathological features of Huntington disease in the full-length BACHD and YAC128 mice (Q45306356) (← links)
- N-terminal polyglutamine-containing fragments inhibit androgen receptor transactivation function (Q46323996) (← links)
- Preventing mutant huntingtin proteolysis and intermittent fasting promote autophagy in models of Huntington disease (Q51238345) (← links)
- Towards humane end points: behavioural changes precede clinical signs of disease in a Huntington's disease model. (Q51703519) (← links)
- Sexual behavior and testis morphology in the BACHD rat model. (Q55159264) (← links)
- A patient-derived cellular model for Huntington's disease reveals phenotypes at clinically relevant CAG lengths. (Q64882921) (← links)
- PiDose: an open-source system for accurate and automated oral drug administration to group-housed mice (Q97522636) (← links)